Observational Study
Copyright ©The Author(s) 2020.
World J Gastrointest Surg. Apr 27, 2020; 12(4): 178-189
Published online Apr 27, 2020. doi: 10.4240/wjgs.v12.i4.178
Table 4 Analysis of lymph node size and response to neoadjuvant treatment
No.Pre-op CRTPre-CRT Size(mm)Post-CRT Size(mm)LN positivityRemarks
1Yes66No
2Yes85No
3No7NANoPrevious radiation for prostate cancer
4Yes80NoEnlarged LPLN resolved after CRT
5Yes7/7 (L/R)4/6 (L/R)No
6Yes1110No
7Yes85No
8No15NAYesNeuroendocrine tumor
9Yes108No
10Yes11/8 (L/R)7/8 (L/R)YesOnly the left side was positive for metastases
11Yes108Yes
12No6NANoNot suitable for CRT in view of performance status and poor social support
13Yes55Yes
14Yes97No
15Yes10NAYesIsolated LPLN recurrence after TME surgery 1 yr ago
16No10NAYesNeuroendocrine tumor
17Yes1111No
18Yes115No
19Yes1410Yes
20Yes66No
21Yes77No
22Yes76Yes